Cooperation In The Field Of Health Tourism Between China And Turkey
Cooperation in the field of health tourism between China and Turkey
A cooperation agreement was signed between Yiling Pharmaceutical, which operates in the field of biopharmaceuticals in China, and Turkishdoc, one of Turkey’s leading health tourism companies. Accordingly, the pharmaceutical factory to be established in Turkey will become the production center for Yiling Pharmaceutical products for the Middle East, Europe, and North African markets.
An important cooperation agreement was reached between Turkey and China at the 2022 China International Digital Economy Fair (CIDEE), which took place in the past few days. The agreement was signed by both Turkishdoc and Yiling Pharmaceutical companies to support the increasing health needs of society.
GOAL FOR INVESTMENT OF 100 MILLION EUROS
Turkishdoc Chairman of the Board Faik Göksu, who stated that they will make significant investments in the health sector with the agreement, said, “Our common goal is to realize an investment of 100 million euros that will make Turkey a production center for the Middle East, North Africa, and European markets in 3 years. “We anticipate to employ 1500 people,” he added.
EMPLOYMENT OPPORTUNITY FOR 1,500 PEOPLE
Pointing out that the interest in health tourism has increased exponentially, Göksu said, “The demands from China, which has a deep-rooted medical tradition and history, from Turkey are also proof of how developed and reliable we are in the field of health. We are the first company to carry out health tourism from China to Turkey. We have four offices there. “We plan to increase the number of these offices in the upcoming period.”